Sentence examples for approach to delay from inspiring English sources
Thus, accumulative evidence suggests that an early integrated strategy, combining pharmacological, immunological, nutritional and life-style factors, is the most pragmatic approach to delay the onset and progression of age-associated dementia.
"I do absolutely think that this is part of an approach to delay the inevitable: The city has to deal with this inequitable, discriminatory system that had no rhyme or reason to it," said Jonathan Lippman, the state's former chief judge and a partner at the law firm Latham & Watkins, which is representing the plaintiffs.
Among the restorative therapeutic approaches, we present here retinal transplantation as an approach to delay the secondary cone degeneration and, consequently, the central vision loss in RP.
It promises to become a standard approach to delay Gal4-driven transgene expression and enhance the genetic toolkit for the zebrafish.
Thus, targeting calpain-1 is a potential approach to delay or reverse the age-associated arterial remodeling that is also associated with diseases such as hypertension, atherosclerosis, and stroke.
Preventing the deterioration of synaptic degeneration is therefore an important therapeutic approach to delay the progression of AD.
Cross-charging is based on the Swedish approach to delayed discharge, which includes cash transfers and penalties between health and social services.
Retardation of aging processes is a plausible approach to delaying the onset or slowing the progression of common neurodegenerative disorders.
This review provides some evidence that the use of vitamins and DHA for the aging population in general, and for individuals at risk in particular, is a viable alternative approach to delaying brain aging and for protecting against the onset of AD pathology.
Targeted strategies to ameliorate these axonal changes may provide a new approach to delaying the cascade of intracellular changes in other diseases with axonal damage.
We are investigating the basis for the persistence of tumor-specific CD8 T cells in the tumor tissue and developing approaches to delay the tolerance induction and reactivate the persisting tolerized CD8 T cells.
